492 related articles for article (PubMed ID: 28102773)
1. The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism - still a challenging issue.
Elmi G; Di Pasquale G; Pesavento R
Vasa; 2017 Mar; 46(2):87-95. PubMed ID: 28102773
[TBL] [Abstract][Full Text] [Related]
2. The secondary prevention of venous thromboembolism: Towards an individual therapeutic strategy.
Elmi G; Pizzini AM; Silingardi M
Vascular; 2018 Dec; 26(6):670-682. PubMed ID: 29966487
[TBL] [Abstract][Full Text] [Related]
3. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
[TBL] [Abstract][Full Text] [Related]
4. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
Hillis C; Crowther MA
Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
[TBL] [Abstract][Full Text] [Related]
5. Extended anticoagulation after venous thromboembolism: should it be done?
Fernandes CJ; Calderaro D; Piloto B; Hoette S; Jardim CVP; Souza R
Ther Adv Respir Dis; 2019; 13():1753466619878556. PubMed ID: 31558116
[TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M
J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830
[TBL] [Abstract][Full Text] [Related]
7. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
8. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.
Prandoni P; Milan M; Sarolo L; Zanon E; Bilora F
Int Angiol; 2017 Oct; 36(5):395-401. PubMed ID: 27982558
[TBL] [Abstract][Full Text] [Related]
9. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach.
Black SA; Cohen AT
Thromb Haemost; 2015 Oct; 114(4):660-9. PubMed ID: 26084864
[TBL] [Abstract][Full Text] [Related]
11. Update on extended treatment for venous thromboembolism.
Peñaloza-Martínez E; Demelo-Rodríguez P; Proietti M; Soria Fernández-Llamazares G; Llamazares-Mendo C; Álvarez-Sala Walther L; Marra AM; Del Toro-Cervera J
Ann Med; 2018 Dec; 50(8):666-674. PubMed ID: 30345825
[TBL] [Abstract][Full Text] [Related]
12. Great Debates in Vascular Medicine: Extended duration anticoagulation for unprovoked venous thromboembolism - Coming to consensus when the debate rages on.
Kanthi Y; Piazza G
Vasc Med; 2018 Aug; 23(4):384-387. PubMed ID: 29734862
[No Abstract] [Full Text] [Related]
13. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.
Sobieraj DM; Coleman CI; Pasupuleti V; Deshpande A; Kaw R; Hernandez AV
Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564
[TBL] [Abstract][Full Text] [Related]
14. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
15. The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough?
Prandoni P; Piovella C; Spiezia L; Dalla Valle F; Pesavento R
Panminerva Med; 2012 Mar; 54(1):39-44. PubMed ID: 22278115
[TBL] [Abstract][Full Text] [Related]
16. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism.
Bauer KA
JAMA; 2011 Apr; 305(13):1336-45. PubMed ID: 21386068
[TBL] [Abstract][Full Text] [Related]
17. Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials.
Wang W; Su Y; Wu C; Sun Y; Dai N; Chen W; Zhang J; Xu Y; Brindis RG; Xu D; Li J
BMC Cardiovasc Disord; 2020 Feb; 20(1):53. PubMed ID: 32013892
[TBL] [Abstract][Full Text] [Related]
18. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.
Palareti G; Antonucci E; Mastroiacovo D; Ageno W; Pengo V; Poli D; Testa S; Tosetto A; Prandoni P
J Thromb Haemost; 2018 Oct; 16(10):1994-2002. PubMed ID: 30059189
[TBL] [Abstract][Full Text] [Related]
19. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
Djulbegovic M; Lee AI; Chen K
J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
[TBL] [Abstract][Full Text] [Related]
20. Treatment of venous thromboembolism.
Wells PS; Forgie MA; Rodger MA
JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
